Diagnostics

Feed My Starving Children calls for 3,000 volunteers for its 10th anniversary event at Target Field, highlighting a decade of local action for global aid.

With $2.5M in seed funding, Hamilton's Stoked Bio is using a novel AI platform to tackle the world's toughest diseases, from superbugs to brain cancer.

A startup's radical new model, born from a family's health crisis, directs all pediatric revenue to fund rare disease research and support families.

A new partnership brings the Aplio i800 EUS to the U.S., offering advanced imaging to improve early, less invasive diagnosis of complex GI conditions.

A new partnership aims to create a continuous data stream from surgery to recovery, using AI to predict and prevent costly gastrointestinal complications.

A national PSA campaign by Allergy & Asthma Network aims to combat severe health disparities and empower millions to manage their asthma effectively.

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

Mount Sinai adopts Echo IQ's AI to improve detection of aortic stenosis, a deadly but often-missed heart condition, heralding a new era for cardiac care.

Once a photography giant, Fujifilm's pivot to healthcare and tech has earned it a top spot on TIME's Most Influential list. Here’s the story of its rebirth.

A local charity born from a father's love is honored for its global work using gaming and VR to bring emotional relief to thousands of hospitalized children.

With fresh capital, the Swedish biotech is scaling its revolutionary platform that decodes cellular communication, fueling a major US expansion.

A tiny brush, engineered to micron-level precision, is at the forefront of a high-tech shift in medical manufacturing, enabling the future of robotics and AI.

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

With a 104B-parameter AI and soaring revenue, Diagens is industrializing diagnostics. Can its ambitious 'Model-as-a-Service' clear global regulatory barriers?

New at-home tests for IBS and SIBO are gaining validation, promising faster diagnoses and revealing surprising links between gut health and systemic diseases.

The clinical trial leader renewed a key global certification, signaling a new era of quality and trust that could accelerate breakthroughs in Alzheimer's.

A new study shows RIVANNA's Accuro XV allows staff with minimal training to get diagnostic images, promising to speed up care and reduce ER wait times.

A new device gets the CE Mark to modernize a 60-year-old cardiac test, promising clearer, faster diagnosis of shunts linked to stroke in millions.

Once a hospital disinfectant, hypochlorous acid is now a skincare star. Magic Molecule's massive CVS launch signals a major shift in the beauty industry.